Ironridge BioPharma to Invest $500,000 in Pressure BioSciences
09 avr. 2012 08h15 HE
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., April 9, 2012 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company") today announced that it has entered into a definitive agreement with Ironridge...
Pressure BioSciences Common Stock to Begin Trading Today on the OTCQB(TM) Tier of the OTC Marketplace
05 avr. 2012 09h59 HE
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., April 5, 2012 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that its common stock will begin trading on the OTCQB tier of...
Pressure BioSciences and Sage-N Research to Collaborate on Improving the Extraction and Analysis of Integral Cell Membrane Proteins That May be Associated With Cancer, Stroke, and Other Diseases and Disorders
19 mars 2012 10h35 HE
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass. and MILPITAS, Calif., March 19, 2012 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI" and the "Company"), a leading sample preparation tools company for the...
Dr. Henry C. Lee, One of the World's Leading Forensic Scientists, to Investigate the Use of Pressure BioSciences' Enabling Pressure Cycling Technology ("PCT") Platform for Use in Multiple Areas of Forensic Analysis
09 mars 2012 07h31 HE
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., March 9, 2012 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI" or the "Company") today announced that it has entered into a collaboration with the Henry C. Lee...
NASDAQ Panel Grants Pressure BioSciences' Request for Continued Listing Pursuant to an Extension
08 mars 2012 09h34 HE
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., March 8, 2012 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI" or the "Company") today announced that on March 7, 2012, the Company received notice that the...
New Data Indicate Pressure BioSciences' Novel Technology Platform Offers Great Promise to the Areas of Biomarker Discovery and Drug Development
07 mars 2012 09h47 HE
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., March 7, 2012 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI" and the "Company") today announced that data supporting important advantages of PBI's powerful...
Pressure BioSciences, Inc. Continues Expansion of European Sales Reach With Distribution Agreement for the Benelux Countries
01 mars 2012 09h29 HE
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., March 1, 2012 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI" or the "Company") today announced that it has entered into a distribution agreement with...
Pressure BioSciences, Inc. to Discuss Fourth Quarter and FY2011 Financial Results and Provide Business Update
29 févr. 2012 13h56 HE
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., Feb. 29, 2012 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) today announced that the Company will host a teleconference to discuss its Q4 and FY2011 financial...
Pressure BioSciences, Inc. Reports 2011 Financial Results
28 févr. 2012 12h47 HE
|
Pressure BioSciences, Inc.
Revenue Up 66% in Second Half Over First Half;
Pace of Consumables Sales Increased Significantly in Second Half 2011
SOUTH EASTON, Mass., Feb. 28, 2012 (GLOBE NEWSWIRE) -- Pressure BioSciences,...
Pressure BioSciences, Inc. Closes $800,000 Private Placement
08 févr. 2012 10h06 HE
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., Feb. 8, 2012 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI" or the "Company") today announced that it has closed on an $800,000 private placement with the...